Physician profile
William Yang
NPI 1790979011
$10,005.48
in general payments reported to CMS, 2019-2025
22 companies · $5,951 in 2025
The $5,951 reported for 2025 was more than what 94% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $402 · 2020: $429 · 2021: $224 · 2022: $194 · 2023: $419 · 2024: $2,386 · 2025: $5,951.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,563 · Food and Beverage: $1,195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,562.50 |
| Food and Beverage | $1,194.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vifor Pharma, INC. | $7,645.17 | 2024-2025 | Veltassa |
| Novartis Pharmaceuticals Corporation | $491.00 | 2019-2023 | |
| Tarsus Pharmaceuticals, INC. | $276.73 | 2024-2025 | Xdemvy |
| Allergan, INC. | $250.67 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $235.96 | 2024-2025 | Vyzulta, Miebo, Xiidra |
| Johnson & Johnson Surgical Vision, INC. | $195.28 | 2023 | Tecnis Simplicity, Catalys System, Tecnis Iol |
| Alcon Vision LLC | $161.82 | 2019-2025 | Rocklatan |
| Omeros Corporation | $146.93 | 2019 | |
| Dompe US, INC. | $139.16 | 2019-2023 | Oxervate |
| Sun Pharmaceutical Industries INC. | $135.84 | 2019-2025 | Cequa |
| Glaukos Corporation | $67.10 | 2020-2025 | Kxl System (Not Refurbished), Photrexa Viscous and Photrexa |
| Abbvie INC. | $45.58 | 2022-2025 | |
| Shire North American Group INC | $33.43 | 2019 | |
| Astellas Pharma US INC | $31.48 | 2025 | Izervay |
| Mallinckrodt Hospital Products INC. | $25.68 | 2023 | Acthar |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $22.45 | 2023 | Rxsight Injector Handpiece, Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Optos, INC. | $22.14 | 2019 | |
| Rayner Intraocular Lenses Limited | $19.21 | 2024 | Omidria |
| Kala Pharmaceuticals, INC. | $16.32 | 2021 | |
| Eyevance Pharmaceuticals LLC | $15.50 | 2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $15.11 | 2019 | |
| Horizon Therapeutics Plc | $12.92 | 2023 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.